Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4987046
rs4987046
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs56070345
rs56070345
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs587776650
rs587776650
NBN
A 0.700 CausalMutation CLINVAR

dbSNP: rs587781803
rs587781803
BRCA2
A 0.700 CausalMutation CLINVAR

dbSNP: rs63750695
rs63750695
PMS2
C 0.700 CausalMutation CLINVAR

dbSNP: rs778705666
rs778705666
DPH1
0.700 GeneticVariation UNIPROT

dbSNP: rs80187739
rs80187739
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80356898
rs80356898
BRCA1
A 0.700 CausalMutation CLINVAR

dbSNP: rs80356993
rs80356993
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357233
rs80357233
BRCA1
C 0.700 CausalMutation CLINVAR

dbSNP: rs80357438
rs80357438
BRCA1 ; NBR2
T 0.700 CausalMutation CLINVAR

dbSNP: rs80357462
rs80357462
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357474
rs80357474
BRCA1
0.700 GeneticVariation UNIPROT

dbSNP: rs80357669
rs80357669
BRCA1
T 0.700 CausalMutation CLINVAR

dbSNP: rs80357828
rs80357828
BRCA1
G 0.700 CausalMutation CLINVAR

dbSNP: rs80358479
rs80358479
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80358981
rs80358981
BRCA2
T 0.700 CausalMutation CLINVAR

dbSNP: rs80359078
rs80359078
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80359176
rs80359176
BRCA2
0.700 GeneticVariation UNIPROT

dbSNP: rs80359477
rs80359477
BRCA2
G 0.700 CausalMutation CLINVAR

dbSNP: rs869312756
rs869312756
ATM
T 0.700 GeneticVariation CLINVAR

dbSNP: rs869312774
rs869312774
PALB2
C 0.700 CausalMutation CLINVAR

dbSNP: rs28897696
rs28897696
BRCA1
0.010 GeneticVariation BEFREE Any one of four germ-line mutations in the C-terminal region found in patients with breast or ovarian cancer (Ala-1708-->Glu, Gln-1756 C+, Met-1775-->Arg, Tyr-1853 ->Stop), had markedly impaired transcription activity. 8942979

1996
dbSNP: rs1800709
rs1800709
BRCA1
0.010 GeneticVariation BEFREE R841W is likely to be an etiologically significant lesion with involvement in close to 1% (95% confidence interval of 0-1.7%) of all breast and ovarian cancers in this population. 8968716

1996
dbSNP: rs2227564
rs2227564
PLAU ; C10orf55
0.010 GeneticVariation BEFREE In order to elucidate the possible role of the Pro121Leu exchange in uPA and the Ala/Thr variants in the signal sequence of PAI-1 in the development and/or progression of human ovarian cancer, we studied the presence of these mutants or variants in a series of 22 ovarian cancer tissues. 9194591

1997